🎯 check Buparlisib (BKM120) product page
Buparlisib (BKM120) is a potent, selective, ATP-competitive pan-PI3K inhibitor. It affects the PI3K/AKT/mTOR signaling pathway by downregulating AKT phosphorylation, effectively inhibiting tumor cell proliferation and inducing apoptosis.